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Abstract
Many persons infected with hepatitis C virus (HCV) are unknown to the healthcare system 
because they may be asymptomatic for years, have not been tested for HCV infection, and only 
seek medical care when they develop liver-related complications. We analyzed data from persons 
who tested positive for past or current HCV infection during participation in the National Health 
and Nutrition Examination Survey (NHANES) from 2001 through 2008. A follow-up survey was 
conducted 6 months after examination to determine (1) how many participants testing positive for 
HCV infection were aware of their HCV status before being notified by NHANES, (2) what 
actions participants took after becoming aware of their first positive test, and (3) participants’ 
knowledge about hepatitis C. Of 30,140 participants tested, 393 (1.3%) had evidence of past or 
current HCV infection and 170 (43%) could be contacted during the follow-up survey and 
interviewed. Only 49.7% were aware of their positive HCV infection status before being notified 
by NHANES, and only 3.7% of these respondents reported that they had first been tested for HCV 
because they or their doctor thought they were at risk for infection. Overall, 85.4% had heard of 
hepatitis C; correct responses to questions about hepatitis C were higher among persons 40-59 
years of age, white non-Hispanics, and respondents who saw a physician after their first positive 
HCV test. Eighty percent of respondents indicated they had seen a doctor about their first positive 
HCV test result.
Conclusion—These data indicate that fewer than half of those infected with HCV may be aware 
of their infection. The findings suggest that more intensive efforts are needed to identify and test 
persons at risk for HCV infection.
The estimated number of persons with chronic hepatitis C virus (HCV) infection increased 
from 2.7 million during 1988-19941 to 3.2 million during 1999-2002.2 Many infected 
persons, however, are unknown to the healthcare system because they may be asymptomatic 
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for years, have not been tested for HCV, and only seek medical care for their infection when 
complications occur as part of the natural progression of untreated infection.3 Currently, 
HCV infection is the etiology most frequently associated with newly diagnosed chronic liver 
disease,4 and the effect on healthcare utilization is high. The number of healthcare visits 
associated with hepatitis C increased in ambulatory care settings during 1992-20035 and has 
remained at a high level through at least 2006.6
Ideally, infected persons would have medical management, both to prevent further liver 
damage and to limit transmission to others.7 Few infected persons, however, receive 
antiviral treatment,6,8 in large part because they may be unaware of their infection.8 
Understanding the characteristics of persons who are unaware of their infection can help 
target appropriate education, but unfortunately, little is known about such individuals. In 
addition, little is known about the implementation of management guidelines by providers.
In this study, we analyzed data from participants who tested positive for past or current 
HCV infection and were interviewed as part of the Hepatitis C Follow-up Survey during the 
National Health and Nutrition Examination Survey (NHANES) conducted from 2001 
through 2008. Three primary objectives of the follow-up survey were (1) to determine the 
percentage of participants testing positive for past or current HCV infection who were aware 
of their HCV status before being notified by NHANES, (2) to learn what actions participants 
took after becoming aware of their first positive test result, regardless of when they were 
made aware of the first positive test result, and (3) to find out what participants or the 
parents of participants <18 years in age knew about hepatitis C.
Participants and Methods
Survey
The NHANES, conducted by the Centers for Disease Control and Prevention’s (CDC) 
National Center for Health Statistics (NCHS), obtains nationally representative data on the 
health and nutritional status of the noninstitutionalized, civilian population of the United 
States. The NHANES uses a complex, stratified, and multistage probability sampling design 
and collects information from approximately 5,000 persons per year using standardized 
household interviews, physical examinations, and testing of biologic samples. More detailed 
information on the survey design for the NHANES, including approval from the institutional 
review board for data collection and analysis, is available from the survey documentation.9
Participants 6 years of age or older who tested positive for antibody to hepatitis C virus 
(anti-HCV) were sent a report of findings (ROF) letter informing them or the parents of 
participants <18 years of age of their HCV test result and encouraging them to follow up 
with a healthcare provider. The letter also provided information about HCV transmission, 
effect on the liver, and effect on general health. In addition, beginning in 2005-2006, serum 
samples from participants with a positive or indeterminate result for anti-HCV were tested 
for hepatitis C RNA (HCV-RNA); starting in 2007, participants with an indeterminate test 
result for anti-HCV and a positive HCV-RNA also were sent an ROF letter. Because a 
primary aim of the follow-up survey was to assess what actions participants took after 
becoming aware of their first positive test result, attempts to administer a follow-up 
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telephone questionnaire to all those who were sent an ROF letter began 6 months after 
examination (approximately 4-5 months after the ROF letter was mailed) to allow 
participants time to have initiated or implemented actions after notification. Persons ≥18 
years of age were interviewed directly; an adult proxy provided information for participants 
who were <18 years of age and for individuals unable to answer the questions themselves. 
The HCV Follow-up Questionnaire (available at: www.cdc.gov/nchs/nhanes/
nhanes2003-2004/questexam03_04.htm) was mentioned in the informed consent and also in 
the ROF letter.
Bilingual (i.e., English and Spanish) trained interviewers contacted eligible participants by 
telephone for the interview. Participants who lived in households with no telephones were 
sent a letter asking them to call a toll-free number to answer a few questions about their 
hepatitis C results. Participants with communication or cognitive difficulties that made it 
impossible to respond to the questionnaire, and for whom a parent or guardian was not 
available to complete the interview, were excluded.
For the main NHANES survey, participants were interviewed in their homes to ascertain 
demographic characteristics, access to care, and health insurance coverage, using the 
Computer-Assisted Personal Interviewing (i.e., interviewer-administered) system. Having a 
usual source of medical care was determined by responses to the question: “Is there a place 
that {you/sampled person} usually {go/goes} when {you are/he/she is} sick or {you/s/he} 
need{s} advice about {your/his/her} health?”
Laboratory Testing
Qualitative determination of anti-HCV in blood serum or plasma was measured using direct 
solid-phase enzyme immunoassay with an anti-HCV screening enzyme-linked 
immunosorbent assay (ELISA) (Ortho CD VITROS Anti-HCV Immunodiagnostic System; 
Ortho Clinical Diagnostics, Raritan, NJ). Positive specimens were repeated in duplicate 
according to the same procedure. Repeatedly positive specimens were then tested using a 
confirmatory recombinant immunoblotting assay (RIBA) (Chiron RIBA Processor System, 
Chiron RIBA HCV 3.0 Strip SIA; Chiron Corporation, Inc., Emeryville, CA), an in vitro 
qualitative enzyme immunoassay for the detection of anti-HCV in human serum or plasma. 
RIBA-positive samples were reported as confirmed positive for anti-HCV, RIBA-negative 
samples were reported as negative for anti-HCV, and indeterminate results were reported as 
indeterminate. Beginning in 2005-2006, positive and indeterminate samples were further 
tested for HCV-RNA using the COBAS AMPLICOR HCV Test (version 2.0; Roche 
Diagnostics Corp., Indianapolis, IN), an in vitro nucleic acid amplification test for the 
quantitation of HCV-RNA in human serum or plasma on the COBAS AMPLICOR 
Analyzer.
Knowledge of Hepatitis C
To ascertain knowledge about hepatitis C, respondents were asked to respond “True” or 
“False” to a series of statements about hepatitis C transmission and its effect on health.
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NCHS analytic guidelines state that data from the Hepatitis C Follow-up Survey should not 
be used with sample weights to make national estimates because of small sample size and a 
response rate below 50%.10 Therefore, analyses were conducted in SAS 9.211 (SAS 
Institute, Cary, NC) using chi-square and, where appropriate (i.e., small cell sizes), Fisher’s 
exact tests. Percentages reported are percent of respondents, not population estimates. 
Results were considered statistically significant at the 0.05 level.
Data from four cycles (2001-2008) of the Hepatitis C Follow-up Survey were combined 
with demographic information, alcohol use data, and health insurance and healthcare 
utilization data. For some analyses, responses to knowledge questions were dichotomized to 
reflect whether the response given was correct according to the fact sheet sent with the ROF 
letter. Correct responses were coded as “correct”; responses that were incorrect as well as 
responses of “don’t know” and “refused” were coded as “not correct.” This recoding was 
done, in part, to avoid small cells in bivariate analyses testing for differences in the 
proportion of correct responses by factors such as age, gender, and health insurance 
coverage.
Results
Of the 43,655 persons ≥6 years of age sampled in the NHANES 2001-2008, a total of 
34,365 (78.7%) were interviewed and 32,847 (95.6% of those interviewed) were examined. 
Serum samples were available for anti-HCV testing for 30,140 (91.8%) of those examined, 
and of these, 391 (1.3%) were anti-HCV positive. An additional 2 persons from 2007 to 
2008 were anti-HCV indeterminate, but HCV-RNA positive, resulting in 393 persons who 
were eligible for the Hepatitis C Follow-up Survey. From these 393 eligible individuals, 168 
full and two partial interviews were completed for a response rate of 43.3% (170 of 393). 
The major reason for not obtaining a survey was the inability to contact 191 (85.6%) of the 
223 from whom survey responses could not be obtained. Characteristics of those eligible for 
the follow-up survey and of survey respondents and nonrespondents are shown in Table 1. 
Respondents were more likely than nonrespondents to be white non-Hispanic and to have 
health insurance. All subsequent results pertain only to the 170 individuals who tested 
positive for current or past HCV infection and responded to the follow-up survey; therefore, 
these results are not generalizable.
Table 2 shows responses to questions regarding whether the NHANES ROF letter was the 
first time the person had been told they had hepatitis C and whether the person had heard 
specifically of hepatitis C. Of those interviewed, only 84 (49.7%) responded that they had 
been told they had hepatitis C before receiving the letter. Awareness of HCV status was 
more than 2 times higher (57.0% versus 23.7%) among those who reported having health 
insurance coverage and 5 times higher (55.0% versus 10.0%) among those who had a usual 
source of medical care than among those who did not. In addition, those who were not 
previously aware of their infection were more likely to be younger than age 40. Of those 
who were previously aware of their HCV infection, approximately half had known that they 
had hepatitis C for more than 5 years, whereas 14.6% said they had known for about 1 year. 
When those who were aware of their HCV infection before receiving the ROF letter were 
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asked why they were first tested for hepatitis C, only 3 (3.7%) said they or their doctor 
thought they were at risk for hepatitis C; nearly half (46.3%) said they had other blood work 
done for a routine physical that indicated possible liver disease. Additional reasons included 
blood donation (9.7%), symptoms (15.9%), other (18.3%), and don’t know (6.4%). Overall, 
85.4% said they had heard of hepatitis C before receiving the ROF letter, but men and black 
non-Hispanics were less likely than women and those of other race/ethnic groups to have 
previously heard of hepatitis C.
The survey contained a number of questions regarding follow-up with a doctor or other 
healthcare professional in response to the first positive hepatitis C test. “First positive test” 
can refer either to the NHANES test or to a previous positive test. Most respondents 
indicated that they had either seen a doctor or other healthcare professional about their 
hepatitis C result (77.5%) or had an appointment to do so (3.6%). Those who had already 
seen a doctor or other healthcare professional were more likely to have health insurance 
(80.6% versus 64.9%; P = 0.04) and to have a usual source of medical care (91.6% versus 
76.3%; P = 0.01) than those who had not. Of 131 who had seen a doctor or other healthcare 
professional, just over half (51.6%) reported they were told they had hepatitis C and needed 
regular medical follow-up. Approximately one third (31.2%) reported they were told they 
tested positive for hepatitis C, but did not need to do anything or worry about it, and 12 
(9.4%) indicated they had been told something else about their hepatitis C test result.
Of those who were told they had hepatitis C and needed regular medical follow-up (n = 66), 
31 (47.0%) reported having had a liver biopsy performed. Those who reported having a 
biopsy did not differ by age, sex, race/ethnicity, health insurance status, or usual source of 
medical care status from those who did not report having a biopsy. When those who were 
told they had hepatitis C and needed regular medical follow-up were asked whether they had 
been told to avoid or limit alcoholic beverages in the future, 87.7% responded yes, but there 
were no differences in the percentage who had, on average, more than 1 drink per day 
during the past 12 months, based on whether they had been told to avoid or limit alcohol 
(49.9%) or not (50.0%).
Those who were told they had hepatitis C and needed regular medical follow-up were also 
asked a series of questions regarding treatment for hepatitis C. When asked whether they 
had been told that their hepatitis C should be treated with medication, such as interferon and 
ribavirin, just over half (52.9%) said yes, and of those, 61.8% indicated they were treated 
with these medications. Those who said they were told they should be treated did not differ 
by age, sex, race/ethnicity, or having health insurance or a usual source of medical care from 
those who said they were not told they should be treated.
The progression of respondents through their encounters with the healthcare system 
regarding their positive test results is shown in Fig. 1. One hundred and seventy of 393 
survey-eligible individuals responded to the survey, 131 of those 170 had seen a physician 
or other healthcare professional about their first positive HCV test, 66 had been told medical 
follow-up was needed, and 22 were treated for their HCV infection.
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Table 3 summarizes the assessment of respondents’ knowledge about hepatitis C. High 
proportions of respondents answered the knowledge questions correctly, with correct 
responses ranging from 57.1% to 95.7%. However, three of the eight questions regarding 
transmission of HCV had relatively lower proportions of correct responses: whether the 
virus could be transmitted by kissing, sexually, and vertically (i.e., mother-child). The 
question about vertical transmission had the highest proportion of “don’t know” responses.
Dichotomized responses (i.e., correct versus incorrect) to the knowledge questions were 
tested for differences in proportion with a correct response by age, sex, race/ethnicity, 
having health insurance, having a usual source of medical care, whether the respondent had 
heard of hepatitis C before receiving the ROF letter, whether the respondent had been aware 
of their HCV infection before receiving the ROF letter, and whether the respondent had 
visited a doctor or other healthcare professional about their first positive HCV test result. 
Significant differences were found by age, sex, and race/ethnicity (Table 4), by having heard 
of hepatitis C before receiving the ROF letter, having been aware of their HCV infection 
before receiving the ROF letter, and having visited a doctor or other healthcare professional 
about their first positive HCV test result (Table 5).
Table 4 should be interpreted as follows: for the first question (“If someone is infected with 
hepatitis C virus, they will most likely carry the virus all their lives”), 65.5% of those 40 or 
younger, 79.7% of those 40-49, 83.7% of those 50-59, and 57.7% of those 60 or older gave a 
correct response to the question. The percentage of correct responses differed by both age 
and race/ethnicity for some questions. Because age did not differ statistically significantly 
across race/ethnic groups for respondents, age-standardized analyses were not performed.
Regarding differences by age, those who were 60 or older were significantly less likely to 
respond correctly to all questions except those regarding vertical transmission and 
transmission by blood transfusion, needle stick, and injection drug use. Those who were 40 
or younger were less likely to have given a correct response to the question regarding 
whether an infected person is likely to carry HCV all their life. For one question (“Someone 
with hepatitis C can look and feel fine”), the difference is not reported as significant, in spite 
of a chi-square P < 0.05, because the test may not be valid as a result of a large number of 
small cells.
Significant differences in the proportion of correct responses were also found for some of 
the knowledge questions by race/ethnicity. The proportion who responded correctly to the 
question about vertical transmission was low for all race/ethnic groups. Black non-Hispanics 
were less likely to respond correctly to the questions regarding carrying HCV for life, as 
well as transmission by shaking hands with or kissing an HCV-infected person or by 
injection drug use. As a group, Hispanics, those of other races, and those who reported 
multiple races were also less likely to have given a correct response regarding transmission 
by kissing. For the questions regarding transmission by blood transfusion and by needle 
stick, differences are not reported as significant, in spite of a chi-square P < 0.05, because 
the test may not be valid as a result of a large number of small cells (e.g., blood transfusion) 
or to a zero cell (e.g., needle stick). Male and female respondents differed only on the 
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question regarding transmission by blood transfusion, with 98.3% of females having given a 
correct response, compared to 86.5% of males (Fisher’s exact two-sided test; P = 0.008).
Table 5 shows the percent of respondents with a correct response to each of the knowledge 
questions based on having heard of hepatitis C before receiving the ROF letter, having been 
aware of their HCV infection before receiving the ROF letter, and having visited a doctor or 
other healthcare professional about their first positive HCV test result. Thus, for the first 
question (“If someone is infected with hepatitis C virus, they will most likely carry the virus 
all their lives”), approximately three quarters of those who had heard of hepatitis C before 
receiving the ROF letter and approximately 60% of those who had not heard of hepatitis C 
before receiving the ROF letter gave a correct response to the question.
Respondents who had heard of hepatitis C before receiving the ROF letter were significantly 
more likely than those who had not previously heard of hepatitis C to respond correctly to 
three of the questions: “If someone is infected with hepatitis C virus, they will most likely 
carry the virus all their lives”; “Infection with the hepatitis C virus can cause the liver to stop 
working”; and “Someone with hepatitis C can look and feel fine.” Respondents who 
reported having seen a doctor or other healthcare professional about their first positive HCV 
test result were more likely to respond correctly to the first two of those three questions plus 
the question regarding transmission by injection drug use than those who had not. 
Respondents who knew they were HCV positive before the ROF letter were significantly 
less likely than those who were unaware they were HCV positive to have responded 
correctly to the question regarding vertical (i.e., mother-child) transmission.
Discussion
Based on the sample of individuals who responded to the Hepatitis C Follow-Up Survey 
after having tested positive for past or current HCV infection during NHANES 2001-2008, 
we found that 49.7% were not aware they were infected with HCV before receiving 
notification from NHANES; more than 80% saw a doctor or other healthcare professional 
about their first positive HCV test or had an appointment to do so, and for most of the 11 
knowledge questions, approximately 75% of respondents provided a correct answer about 
hepatitis C and its transmission. Of those who were aware of their positive HCV infection 
status before being notified by NHANES, only 3.7% reported that they had first been tested 
for HCV because they or their doctor thought they were at risk for this infection. Overall, 
85.4% of those who were infected had heard of hepatitis C before receiving the ROF letter; 
correct responses to specific questions about hepatitis C were higher among persons 40-59 
years of age, white non-Hispanics, and those who saw a physician regarding their first 
positive HCV test.
Approximately one half of the respondents had not been aware of their HCV status before 
receiving the ROF letter. We found that those 40-59 years of age were more likely to be 
aware of their HCV status than were those who were either younger or older. This is 
encouraging, because the burden of HCV disease is highest among those 40-59 years of age. 
Respondents who were not previously aware of their infection were more likely to lack 
health insurance coverage and a usual source of medical care. This suggests that screening 
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efforts for HCV that work through the healthcare system may not be successful in reaching 
many HCV-infected individuals because of lack of health insurance coverage and/or lack of 
a usual source of medical care.
Only 3.7% of those who were previously aware of their HCV status reported that they had 
first been tested because they or their doctor thought that they were at risk for hepatitis C. 
Nearly half reported they had first been tested based on results from a routine physical. 
These findings are consistent with patterns in primary care12 and suggest a lack of 
effectiveness in the current risk-based screening strategy. Risk-based screening might fail 
because providers may not elicit complete risk-factor histories13 or patients deny risk 
behaviors.14 Regardless of the reason, our results suggest that the current risk-based 
screening is not being implemented for a large number of infected individuals during their 
encounters with the healthcare system. This is particularly important, because 70%-85% of 
HCV-infected individuals are asymptomatic, making serological testing the major avenue by 
which their infection will be discovered.
Approximately one third of respondents who had seen a doctor or other healthcare 
professional about their positive HCV test result reported that they were told they had tested 
positive for hepatitis C, but did not need to do anything or worry about it. This message 
would be appropriate for anti-HCV-positive individuals with either resolved or previously 
treated infections; however, 23 of 29 such individuals with HCV-RNA results available 
were, in fact, HCV-RNA positive when tested during the NHANES. There are a number of 
reasons why patients who were HCV-RNA positive when tested by NHANES may have 
reported being told they did not need to do anything or worry about their positive HCV test 
result, including the following: The respondent misunderstood or misreported what they 
were told; a negative HCV-RNA test result was obtained at follow-up because those 
chronically infected with HCV can have intermittent viremia; an individual had been treated 
and reinfected; or their physician did not know how to manage a chronically infected case. 
Each of these latter reasons suggests the need for patient and provider education to ensure 
that correct messages are given and understood.
It is encouraging to note that more than 80% of respondents had either already seen a doctor 
or healthcare professional about their first positive test results or had an appointment to do 
so. However, having health insurance coverage or a usual source of medical care affected 
whether a person testing positive for HCV had seen a doctor or other healthcare 
professional. Figure 1 highlights a dramatic decline in the number of patients at each stage 
as they progress from seeing a physician about their positive test results to treatment for 
HCV infection. Only 12.9% (22 of 170) from this sample were treated for their infection. In 
contrast, facility-based studies suggest treatment rates closer to 30%-40%.15 With the 
approval of new medications (www.fda.gov/ForConsumers/ByAudience/
ForPatientAdvocates/ucm151488.htm), treatment rates for HCV are expected to improve 
and monitoring their impact will be essential.
Our finding that approximately three quarters of the respondents knew the correct answer to 
most of the knowledge questions is encouraging. We found that incorrect responses to a 
number of questions were significantly associated with black non-Hispanic race/ethnicity 
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and older or younger age than 40-59 years, two factors that were also associated with survey 
non-response (black non-Hispanic), having heard of hepatitis C before the ROF letter (black 
non-Hispanic), and being unaware of their HCV infection before the ROF letter (younger 
age), thus suggesting these same groups for targeted prevention efforts. We cannot know 
whether the source of the knowledge was the fact sheet that accompanied the ROF letter 
(either because they had read and learned from it or had it at hand during the interview), a 
healthcare provider, or some other source. However, because the interview was conducted 
4-5 months after receipt of the fact sheet and letter, it is less likely that respondents would 
have the fact sheet at hand. Furthermore, one of the questions with a lower frequency of 
correct responses was regarding vertical transmission of HCV, a topic included in the fact 
sheet.
Two other questions had a relatively low frequency of accurate responses: whether HCV 
could be transmitted sexually or by kissing an infected person. The first of these, sexual 
transmission, may require a more specific question to accurately assess knowledge. For 
example, sexual transmission of HCV among men who have sex with men with human 
immunodeficiency virus (HIV) infection has been documented, whereas risk of transmission 
among monogamous non-HIV-infected heterosexual partners is rare or nonexistent.16 The 
lower frequency of correct responses to transmission from kissing an infected person might 
be a result of the fact that this was not explicitly stated on the fact sheet or may reflect a lack 
of understanding about HCV transmissibility.
Approximately 15% of respondents had not heard of hepatitis C before receiving the ROF 
letter; this proportion was higher for men and black non-Hispanics, among whom the burden 
of HCV disease is higher, and for persons lacking health insurance or a usual source of 
medical care. We think it is noteworthy that having previously heard of hepatitis C did not 
vary by age group. These findings may serve as a roadmap for education programs to 
prevent infection, because there is currently no vaccine available for HCV. Clearly, more 
work is needed to bring this disease of public health importance to the attention of the U.S. 
population, especially those in the subgroups most affected by the disease. The 2010 
Institute of Medicine report identified a lack of education about HCV among the public and 
among healthcare providers as an important barrier to controlling the HCV epidemic in the 
United States.17 The CDC plans to expand efforts to educate both the public and providers; 
continued monitoring of the effect of education on prevention is warranted.
As with all studies, there are limitations to consider when interpreting these findings. First, 
NHANES data are generalizable to the U.S. noninstitutionalized civilian population and 
exclude the homeless, persons living in correctional institutions, and other group quarters 
(e.g., student dormitories, military recruits). Second, although the Hepatitis C Follow-up 
Survey is nested within the NHANES, the data from the follow-up survey cannot be used to 
generate population estimates because of the small number of respondents and low response 
rate. Frequencies for some questions may be affected by differences in characteristics of 
respondents and nonrespondents. In addition, the small sample size limited our power to 
detect statistically significant differences between subgroups. Third, the data are self-
reported and therefore subject to the usual biases associated with such data (e.g., recall bias), 
including possibly not understanding questions regarding medical information, such as 
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whether they have had a particular medical procedure performed or what they were told by a 
healthcare provider. Finally, the sample consisted of persons who were positive for anti-
HCV, whether currently infected or not; thus, treatment would not have been indicated in all 
those who received an ROF letter—however, 91 of 115 with HCV-RNA results available 
were HCV-RNA positive when tested during the NHANES, suggesting chronic infection.
In summary, we report results for a sample of NHANES participants who responded to a 
follow-up survey after having tested positive for past or current HCV infection from 2001 
through 2008, which, to our knowledge, is the only survey of such individuals to be 
conducted as part of a national population-based study. These data indicate that fewer than 
half of those infected with HCV may be aware of their infection. The findings suggest that 
more intensive efforts are needed to identify and test those at risk for HCV infection and the 
need to educate patients and providers about appropriate interaction on prevention decisions 
and actions.
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Table 1
Characteristics of Hepatitis C Follow-up Survey Participants, NHANES Hepatitis C Follow-up Survey, 
2001-2008
Eligible for Follow-up
(n = 393) Respondents (n = 170)
Nonrespondents
(n = 223)
Characteristics n Percent n Percent n Percent P Value*
Age group (years)
 <40 75 19.1 32 18.8 43 19.3
 40-49 148 37.7 59 34.7 89 39.9
 50-59 99 25.2 50 29.4 49 22.0
 60+ 71 18.0 29 17.1 42 18.8 NS
Male 241 61.3 108 63.5 133 59.6 NS
Race/ethnicity
 White non-Hispanic 171 43.5 87 51.2 84 37.7
 Black non-Hispanic 130 33.1 47 27.6 83 37.2
 Hispanic/other/multiple 92 23.4 36 21.2 56 25.1 <0.05
Educational attainment
 Less than high school 146 37.9 56 33.7 90 41.1
 High school graduate/GED 114 29.6 53 31.9 61 27.8
 More than high school 125 32.5 57 34.3 68 31.1 NS
Poverty index
 <1.0 (below poverty) 123 33.0 44 27.0 79 37.6
 1.0-1.9 (near poverty) 120 32.2 60 36.8 60 28.6
 2.0+ (above poverty) 130 34.8 59 36.2 71 33.8 NS
Have health insurance (yes) 273 70.5 128 76.6 145 65.9 <0.05
Have a usual source of medical care
(yes) 339 86.3 150 88.2 189 84.8 NS
More than 1 drink/day (yes) 190 54.0 79 50.3 111 56.9 NS
NS = not significant at p < 0.05 level.
Abbreviation: GED, general educational development.
*
P value for chi-square test of difference between respondents and nonrespondents.
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Table 2
Awareness of Hepatitis C and HCV Infection Status Before NHANES ROF Letter, NHANES Hepatitis C 
Follow-up Survey, 2001-2008
Heard of Hepatitis C Before ROF
Letter
ROF Letter Was First Time
Told Had Hepatitis C
Characteristics Yes % (n) No % (n) P Value Yes % (n) No % (n) P Value
All respondents 85.4 (141) 14.6 (24) – 50.3 (85) 49.7 (84) –
Age group (years)
 <40 86.7 (26) 13.3 (4) 71.0 (22) 29.0 (9)
 40-49 82.8 (48) 17.2 (10) 42.4 (25) 57.6 (34)
 50-59 87.5 (42) 12.5 (6) 44.0 (22) 56.0 (28)
 60+ 86.2 (25) 13.8 (4) NS 55.2 (16) 44.8 (13) <0.05
Sex
 Male 81.0 (85) 19.0 (20) 55.6 (66) 44.4 (48)
 Female 93.3 (56) 6.7 (4) <0.05 41.0 (25) 59.0 (36) NS
Race/ethnicity
 White non-Hispanic 90.6 (77) 9.4 (8) 48.8 (42) 51.2 (44)
 Black non-Hispanic 73.3 (33) 26.7 (12) 57.4 (27) 42.6 (20)
 Hispanic/other/multiple 88.6 (31) 11.4 (4) <0.05 44.4 (16) 55.6 (20) NS
Have health insurance
 Yes 88.0 (110) 12.0 (15) 43.0 (55) 57.0 (73)
 No 78.4 (29) 21.6 (8) NS 76.3 (29) 23.7 (9) <0.001
Have a usual source of medical care
 Yes 86.9 (126) 13.1 (19) 45.0 (67) 55.0 (82)
 No 75.0 (15) 25.0 (5) NS 90.0 (18) 10.0 (2) <0.001*
NS = not significant at P < 0.05 level.
*
Fisher’s exact two-sided probability.
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Table 3
Knowledge of Hepatitis C, NHANES Hepatitis C Follow-up Survey, 2001-2008 (n = 163*)
Hepatitis C Knowledge Question True % (n) False % (n) Don’t Know % (n) Refused % (n)
If someone is infected with HCV, they will most likely carry the virus all 
their lives.
74.8 (122) 9.2 (15) 16.0 (26) 0.0 (0)
Infection with HCV can cause the liver to stop working. 77.3 (126) 3.7 (6) 18.4 (30) 0.6 (1)
Someone with hepatitis C can look and feel fine. 90.2 (147) 2.4 (4) 6.8 (11) 0.6 (1)
You can get hepatitis C by getting a blood transfusion from an infected 
donor.
90.8 (148) 1.2 (2) 7.4 (12) 0.6 (1)
You can get hepatitis C by shaking hands with someone who has hepatitis 
C.
7.4 (12) 84.6 (138) 6.8 (11) 1.2 (2)
You can get hepatitis C by kissing someone who has hepatitis C. 9.8 (16) 68.1 (111) 20.9 (34) 1.2 (2)
You can get hepatitis C by having sex with someone who has hepatitis C. 63.8 (104) 17.8 (29) 17.2 (28) 1.2 (2)
You can get hepatitis C by being born to a woman who had
 hepatitis C when she gave birth.
57.1 (93) 8.0 (13) 33.7 (55) 1.2 (2)
You can get hepatitis C by being stuck with a needle or sharp instrument
 that has hepatitis C–infected blood on it.
95.7 (156) 0.6 (1) 3.1 (5) 0.6 (1)
You can get hepatitis C by working with someone who has hepatitis C. 10.4 (17) 74.9 (122) 13.5 (22) 1.2 (2)
You can get hepatitis C by injecting illegal drugs, even if only a few times. 84.7 (138) 4.9 (8) 9.8 (16) 0.6 (1)
Shading indicates correct response according to fact sheet sent with ROF letter.
*
Total excludes 4 participants who were told by their doctor that they did not have hepatitis C based on follow-up testing and who were therefore 
not asked these questions.
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Table 5
Influence of Selected Factors on Giving a Correct Answer to Hepatitis C Knowledge Questions, Hepatitis C 
Follow-up Survey Respondents, NHANES 2001-2008 (n = 163*)
Factor
Heard of Hepatitis C Before
ROF Letter
Knew You Were 
HCV+Before
ROF Letter
Seen a Doctor About First
Positive HCV Test






















If someone is infected with HCV, they will 
most
 likely carry the virus all their lives.
77.9† 59.3 80.0 69.9 79.2† 60.5
Infection with HCV can cause the liver to 
stop working.
81.6‡ 55.6 83.8 71.1 81.6† 63.2
Someone with hepatitis C can look and 
feel fine.
93.4‡ 74.1 91.2 89.2 92.0 84.2
You can get hepatitis C by getting a blood
 transfusion from an infected donor.
91.2 88.9 91.3 90.4 91.2 89.5
You can get hepatitis C by shaking hands
 with someone who has hepatitis C.
85.3 81.4 90.0 79.5 87.2 76.3
You can get hepatitis C by kissing 
someone
 who has hepatitis C.
68.8 59.3 70.0 66.3 72.0 55.3
You can get hepatitis C by having sex with
 someone who has hepatitis C.
62.5 70.4 61.2 66.3 64.0 63.1
You can get hepatitis C by being born to a 
woman
 who had hepatitis C when she gave 
birth.
53.7 74.1 48.8† 65.1 54.4 65.8
You can get hepatitis C by being stuck 
with
 a needle or sharp instrument that has 
hepatitis
 C–infected blood on it.
96.3 92.6 95.0 96.4 96.8 92.1
You can get hepatitis C by working with
 someone who has hepatitis C.
75.0 74.1 80.0 69.9 86.4 79.0
You can get hepatitis C by injecting illegal 
drugs,
 even if only a few times.
86.8 74.1 86.2 83.1 82.4§ 50.0
*
Total excludes 4 participants who were told by their doctor that they did not have hepatitis C based on follow-up testing and who were therefore 
not asked these questions.
†
P < 0.05 for difference in percentage with correct answer to question regarding hepatitis C by factor status.
‡
P < 0.01 for difference in percentage with correct answer to question regarding hepatitis C by factor status.
§
P < 0.0001 for difference in percentage with correct answer to question regarding hepatitis C by factor status.
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